(Q43866903)

27 November 2017

title

Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections (English)

1 reference

27 November 2017

0 references

1 reference

I M Hoepelman

1

1 reference

27 November 2017

M Rozenberg-Arska

series ordinal

2

1 reference

27 November 2017

J Verhoef

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 June 1988

1 reference

27 November 2017

1 reference

27 November 2017

volume

1

1 reference

27 November 2017

issue

8598

1 reference

27 November 2017

page(s)

1305-1309

1 reference

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

Restriction policies for therapy with combination antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

Pharmacokinetics of ceftriaxone in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

Controlled Comparison of Amikacin and Gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992121-6

7 January 2021

10.1016/S0140-6736(88)92121-6

Identifiers

DOI

1 reference

27 November 2017

1 reference